Well here is hoping the Quarterly Results Call, fiscal Q2 2024,...

Well here is hoping the Quarterly Results Call, fiscal Q2 2024, on January 30, 2024 will appease our collective concerns and we can collectively quibble once we forensically picked it apart. Nub of the frustration -- we are desperately wanting to see the potential pipeline open up in into flowing sales ..that's the bottom line I suspect for the majority of holders

As per the 8 Jan letter

It’s now time to convert our pipeline into sales. This is our top priority in 2024

2023 Year in Review
• First Sales Shipped. In addition to the great network of sales and distribution partners,WOA has begun selling our first direct orders of Buntine Protein® out of Kewdale, and ourfirst order of Prolupin’s isolate, LP90, shipped during December. While initial sales to early adopter customers did not generate material revenues in 2023, we estimate that our pipeline over the next 18 months is in excess of 400 tonnes. Of course, a pipeline must be converted into paid orders fulfilled and delivered. But with the progress made on the integration in Germany, we think we are in a great position to start converting this pipeline and are focused on getting high utilisation as quickly as possible at the Prolupin plant.